Graphic of four workstreams with descriptions

Scaling Cancer Biomarker Testing: Roadmap Brief

This five-page roadmap brief provides an overview of the Scaling Cancer Biomarker Testing Strategic Roadmap for Collective Action, which presents a strategic framework developed by leaders across the cancer care ecosystem at the December 2025 IAC Scaling Biomarker Testing Workgroup Design Meeting.

Access Resource
In December 2025, AcademyHealth convened 35 leaders representing clinical practice, pathology, patient advocacy, health system transformation, implementation science, industry, and policy to review the current state of practice and outline what is needed to advance the field of biomarker testing. This brief summarizes is the product of that convening: a shared strategic framework for bringing cancer biomarker testing to national scale. The roadmap sets out a shared framework for coordinated action: a collective impact approach, six key indicators for measuring progress, four interdependent workstreams, and five foundational activities underway between April and December 2026 to prepare the coalition for full launch.